Skip to main
SYK

Stryker (SYK) Stock Forecast & Price Target

Stryker (SYK) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 28%
Buy 56%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Stryker is a strong contender in the competitive market of medical equipment due to its diverse product portfolio and leadership position in operating room equipment. Its expanding international business and the potential for growth in fast-growing end-markets through strategic M&A add to its positive outlook. However, potential disruptions from recent cyberattacks, increasing competition in orthopedic robotic systems, and execution related to growth and expansion could pose risks to Stryker's performance and sentiment. As a result, it is important to carefully monitor the company's progress in these areas in order to fully evaluate its potential for sustained growth.

Bears say

Stryker is a well-established player in the MedTech industry, but the negative outlook is due to several factors. Firstly, there may be a slowdown in the orthopedic market, which is one of Stryker's key segments, and the company may also face increased competition in the orthopedic robotics space from other major players in the market. Additionally, Stryker's expansion into new markets and revenue streams may not be as successful as expected, and there is also the risk of execution-related challenges with its M&A strategy. These factors could potentially lead to slower revenue and EPS growth, which could negatively impact the company's valuation and investor sentiment.

Stryker (SYK) has been analyzed by 18 analysts, with a consensus rating of Buy. 28% of analysts recommend a Strong Buy, 56% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stryker (SYK) Forecast

Analysts have given Stryker (SYK) a Buy based on their latest research and market trends.

According to 18 analysts, Stryker (SYK) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $391.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $391.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stryker (SYK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.